BioInformatics LLC Announces New Report—Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia
Arlington, VA (PRWEB) January 30, 2014 -- Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia (13-008) provides an in-depth exploration of anticipated lab spend for the year 2014. This primary and secondary research will help you and your team to forecast demand, allocate resources and respond appropriately to the economies of a global market.
“This report is structured in a way that will enable the reader to take data from this report and merge it with prior market research, sales and Customer Relationship Management (CRM) data and other sources of market knowledge to assess how the reader’s individual company is likely to perform in 2014,” says Robin Rothrock, Ph.D., Director of Publications at BioInformatics LLC.
The overarching objective of this study was to assess sources of funding, the competitive landscape and market opportunities in the United States, Europe and Asia for life science tools companies. From the perspective of academic and industrial labs, our goals were to:
1.) Understand current sources of funding from government, industry, private foundation grants, institutional funds, etc., their relative contribution to laboratory funding, and frequency of grant submission.
2.) Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region, and market segment thus providing directional information for FY2014.
3.) Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories.
4.) Assess how optimistic scientists are regarding funding and the future of life science research.
The assessment is based upon an extensive review of secondary research sources to better understand the scope of funding for the life sciences in the United States and Europe, in addition to a primary research component involving a quantitative survey of life scientists working in the United States, Europe and Asia.
Due to popular demand, this report has been made available to a wider audience following early access by the study’s syndicating sponsors. In addition, new purchasing options are available for region-specific sections of the report.
To learn more about this project, a complimentary report brochure is available at:
http://www.gene2drug.com/index.php?page=reports&id=240
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 73,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
For more information contact:
Robin Rothrock, Ph.D.
Director of Publications
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x25 (phone)
r.rothrock(at)gene2drug(dot)com
http://www.gene2drug.com/
Angela Fernandez, BioInformatics LLC, http://www.gene2drug.com, +1 (703) 778-3080 Ext: 14, [email protected]
Share this article